07/09/2026
Multiple Myeloma is a blood cancer that begins in abnormal plasma cells—a type of blood cell found in the bone marrow. As these abnormal cells multiply, they can affect different parts of the body, particularly the bones, blood and kidneys.
But here’s an important message: a diagnosis of Multiple Myeloma does not mean there is no chance of a meaningful life.
Advances in treatment have changed what is possible for many patients. Treatment options can include medications, supportive care, autologous stem cell transplant and, for selected relapsed or refractory patients, newer approaches such as CAR-T cell therapy.
🚨 Know the warning signs
Common symptoms can include:
🔹 Persistent bone pain or bone weakening
🔹 Anaemia and fatigue
🔹 Frequent infections
🔹 Kidney problems
🧬 Where does treatment fit in?
For eligible patients, an autologous stem cell transplant involves collecting the patient's own stem cells, administering high-dose treatment and then returning those stem cells to the patient.
If Multiple Myeloma returns, CAR-T cell therapy may be an option for selected relapsed or refractory patients, where a patient's T cells are collected and engineered to target myeloma cells.
The right treatment depends on the individual patient, disease status, previous treatments and overall clinical assessment.
👉 Swipe through to understand Multiple Myeloma, its warning signs and evolving treatment options.
If you or a loved one has been diagnosed with Multiple Myeloma, seek evaluation from an experienced hematology team to understand the treatment options appropriate for your case.
📞 +91 9211493630
🌐 www.bmtnext.com
Expert care. Advanced solutions. Better outcomes.